NASDAQ : BWAY

BrainsWay Ltd. — Company profile

Healthcare · Medical Devices · Israel

Last price 11.93 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 496.39M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Details

NameBrainsWay Ltd.
SectorHealthcare
IndustryMedical Devices
Employees129
Founded2003
Ipo Date2019-04-17
CeoHadar Levy
CountryIsrael
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
Ipo Price11.00
IsinUS10501L1061
Cusip10501L106
Cik0001505065
Sic3841

Key executives

NameTitle
Hadar LevyChief Executive Officer
Dr. David Zacut M.D.Co-Founder and Vice-Chairman
Prof. Abraham Zangen Ph.D.Co-Founder, Member of Scientific Advisory Board and Director
Ido MaromChief Financial Officer
Dr. Colleen Hanlon Ph.D.Vice President of Medical Affairs
Michael CohenVice President of US Sales
Dr. Yiftach Roth Ph.D.Founder and Chief Scientific Officer
Dor HagaiVice President of Operations
Gilead Moiseyev Ph.D.Chief Technology Officer
Menachem C. Klein Esq.Vice President, General Counsel and Corporate Secretary

Contact

Address16 Hartum St, Har Hotzvim, Jerusalem, 9777516, Israel
Phone972 2 582 4030
Websitehttps://www.brainsway.com